← All trials
NCT00917358
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2005
- Primary completion
- Jun 1, 2008
- Completion date
- Jun 1, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 42
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- National Taiwan UniversityLead sponsor
- Far Eastern Memorial HospitalOverall official - principal investigator
- Chiayi Christian HospitalOverall official - principal investigator
- National Taiwan UniversityOverall official - principal investigator
- National Taiwan UniversityStudy chair
- Tzu Chi UniversityOverall official - principal investigator
- Government of TaiwanCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.